National Genome Strategy aims to establish a comprehensive framework of laws and regulations to support the development and implementation of genomic programmes, improving public health priorities and wellbeing in the UAE. To be implemented over 10 years from the year 2023, it will accelerate solutions for personalised, preventive and precision medicine to combat chronic, genetic and rare diseases.

Pillars

The strategy is based on the following five pillars:

1. establishing an agile framework of legislation and governance
2. creating a harmonised and secure data infrastructure
3. developing distinguished genomic research and innovation capabilities
4. focusing on genomic applications that align with public health priorities
5. building strategic partnerships that accelerate the delivery of best-in-class programmes.

The Emirati Genome Programme is a foundational project within National Genome Strategy. It will advance the UAE’s preventive and personalised healthcare agenda as it collaborates with research and medical institutions across the UAE.

In the presence of Mohamed bin Zayed and Mohammed bin Rashid, the UAE Genome Council has launched the 10-year UAE Genome Strategy – a plan to accelerate solutions for personalised, preventive and precision medicine to combat chronic and genetic diseases. pic.twitter.com/4wYgHpp3FV

— مكتب أبوظبي الإعلامي (@ADMediaOffice) March 28, 2023